Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration
- 1 September 1981
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 48 (3) , 545-553
- https://doi.org/10.1016/0002-9149(81)90086-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.Circulation, 1981
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.Circulation, 1979
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.Circulation, 1979
- Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.Circulation, 1978
- VerapamilDrugs, 1978
- Real-Time Radionuclide Cineangiography in the Noninvasive Evaluation of Global and Regional Left Ventricular Function at Rest and during Exercise in Patients with Coronary-Artery DiseaseNew England Journal of Medicine, 1977
- Asymmetric Septal HypertrophyCirculation, 1973
- New selective inhibitors of the transmembrane Ca conductivity in mammalian myocardial fibres. Studies with the voltage clamp techniqueCellular and Molecular Life Sciences, 1972
- Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic BlockadeCirculation, 1967
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958